Condition

CMV clinical trials and research

• 7Clinical trials
• 4Countries

Newest CMV clinical trials

All recruiting trials (7)

• Letermovir plus standard antiviral to clear CMV in lung transplant recipients

  This will test whether adding letermovir to usual antiviral treatment helps clear CMV in lung transplant recipients with active infection by week 3.

  Recruiting Phase 4 University Health Network, Toronto · Toronto, Ontario · NCT07235683

• Family-donor viral CTLs plus standard care vs standard care alone for refractory ADV or CMV infection after stem cell transplant

  This study tests whether using family-donor virus-specific CTLs in addition to usual treatment helps children, teens, and young adults with hard-to-treat CMV or adenovirus infections after a stem cell transplant.

  Recruiting Phase 3 New York Medical College · Valhalla, New York and 1 other locations · NCT07225972

• Preventing CMV with CMVIG after conversion to belatacept in kidney transplant recipients

  This will try CMVIG infusions to prevent CMV infection in adult kidney transplant recipients who are CMV‑seronegative and are switching to or already on belatacept.

  Recruiting Phase 1/2 University of Minnesota · Minneapolis, Minnesota · NCT07096453

• Preventing CMV Infections in High-Risk Adults After Stem Cell Transplant

  This study is testing if giving a medication called letermovir for longer than usual can help prevent serious CMV infections in high-risk adults after they receive a stem cell transplant.

  Recruiting The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT06812598

• Evaluating CMV Prophylaxis After Stem Cell Transplant

  This study is testing if a new test can help doctors decide how long to give a specific medicine to prevent a virus in patients who have had a stem cell transplant.

  Recruiting Phase 2 University of California, Irvine · Orange, California · NCT06453460

• Preventing Cytomegalovirus Infection After Stem Cell Transplantation

  This study is testing whether giving patients special immune cells from their donors can help prevent Cytomegalovirus infections after they receive a stem cell transplant.

  Recruiting Phase 2 Instituto de Investigación Marqués de Valdecilla · Santander · NCT04056533

• Understanding severe viral infections in patients without known immune issues

  This study is trying to understand why some healthy people get severe viral infections and how different tests can help figure it out.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT01011712

Related topics

Quick answers

How many CMV clinical trials are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 4 countries. The most sites are in United States (4 trials), Canada (1 trial), China (1 trial), Spain (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 2, Phase 4: 1, Phase 1/2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →